Last reviewed · How we verify

NCT05386537

Combining Wearable Robotic Orthosis With Visual and Haptic Feedback to Enhance the Recovery of Upper Extremity Motor Function and ADL in Persons With Acute SCI

Status unknown EARLY_PHASE1 Last updated 6 May 2023
What this trial tests

EARLY_PHASE1 trial testing MyoMo orthosis and VR games in SCI - Spinal Cord Injury in 20 participants. Status unknown.

Timeline
1 April 2021
Primary endpoint
1 October 2024
1 October 2024

Quick facts

Lead sponsorKessler Foundation
PhaseEARLY_PHASE1
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingsingle
Primary purposetreatment
Enrollment20
Start date1 April 2021
Primary completion1 October 2024
Estimated completion1 October 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Kessler Foundation

Who can join

Adults 18 to 80, any sex, with SCI - Spinal Cord Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized clinical trial (RCT) is evaluating the usefulness of combining MyoMo robotic orthosis with visual and haptic feedback in ameliorating wrist/hand/UE movement capability, and increasing ADL and quality of life in people with acute SCI.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Combining Therapeutic Strategies to Treat the Injured Spinal Cord: A Translational Perspective.
    Sherman BC, Schmidt Read M, Hoh DJ, Guest JD, et al · · 2025 · cited 2× · PMID 40929022 · DOI 10.1177/08977151251371710

Verify or expand the search:

Other recruiting trials for SCI - Spinal Cord Injury

Currently open trials in the same condition.

Other Kessler Foundation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05386537.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing